Michael G. Kauffman
2019
In 2019, Michael G. Kauffman earned a total compensation of $3.2M as Chief Executive Officer at Karyopharm Therapeutics, a 42% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $363,693 |
---|---|
Option Awards | $1,486,339 |
Salary | $566,500 |
Stock Awards | $803,112 |
Other | $11,860 |
Total | $3,231,504 |
Kauffman received $1.5M in option awards, accounting for 46% of the total pay in 2019.
Kauffman also received $363.7K in non-equity incentive plan, $566.5K in salary, $803.1K in stock awards and $11.9K in other compensation.
Rankings
In 2019, Michael G. Kauffman's compensation ranked 3,776th out of 13,971 executives tracked by ExecPay. In other words, Kauffman earned more than 73.0% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 3,776 | 73rd |
Manufacturing | 1,366 | 76th |
Chemicals And Allied Products | 477 | 78th |
Drugs | 401 | 79th |
Pharmaceutical Preparations | 302 | 78th |
Kauffman's colleagues
We found three more compensation records of executives who worked with Michael G. Kauffman at Karyopharm Therapeutics in 2019.
News
Karyopharm Therapeutics CEO Richard Paulson receives $8.4M in 2021
April 8, 2022
Karyopharm Therapeutics CEO Michael Kauffman's 2020 pay jumps 22% to $3.9M
April 7, 2021
Karyopharm Therapeutics CEO Michael Kauffman's 2019 pay jumps 42% to $3.2M
April 9, 2020
Karyopharm Therapeutics Executive Vice President, Chief Commercial Officer Anand Varadan receives $2.3M in 2018
April 19, 2019